XIAP antibody | knockout validation | Santa Cruz sc-55551

This is a knockout-validated antibody summary, based on the publication "XIAP facilitates breast and colon carcinoma growth via promotion of p62 depletion through ubiquitination-dependent proteasomal degradation", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

XIAP antibody | knockout validation | Santa Cruz sc-55551 figure 1
Figure 1. Western blot analysis with the indicated antibodies in HCT116 and DLD1 cells with or without XIAP depletion. Please see Figure 3c in the article [1].
Antibody information

Mouse monoclonal IgG2b (kappa light chain)

Company: Santa Cruz

Antibody: XIAP

Catalog number: sc-55551

Summary: Mouse monoclonal IgG2b (kappa light chain) against amino acids 1-202 mapping at the N-terminus of human XIAP. Recommended for detection of XIAP of mouse, rat and human origin by western blot, immunoprecipitation, immunofluorescence and ELISA.

Validation Method

Western blot

Sample

Control and XIAP-KO HCT116 and DLD1 cells.

Blocking agent

7.5% skim milk in TBST for 1 h.

Primary incubation

Overnight at 4 °C according to the manufacturer’s recommendation.

Secondary incubation

HRP-labeled secondary antibodies.

Detection

SuperSignal™ West Femto Maximum Sensitivity Substrate (34095; Thermo Fisher). Visualized images were obtained using ImageQuantTM LAS-4000 (GE Fujifilm) or photographic film.

References
  1. Huang X, Wang X, Yuan X, Wu W, Lobie P, Wu Z. XIAP facilitates breast and colon carcinoma growth via promotion of p62 depletion through ubiquitination-dependent proteasomal degradation. Oncogene. 2018;: pubmed publisher